Term ended Nov 3, 2026 · Medium confidence
20-year base term ended Nov 3, 2026
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 7,767,672), so the cap could be lower.
Nov 3, 2006
Nov 3, 2026
Oct 26, 2010
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 3, 2006, when this application, 11/592,113, was filed | Nov 3, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,767,672) | resolves to Nov 3, 2026, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Nov 3, 2026 | Medium confidence |
This family
| US 7,820,685 | this patent Nov 2026 | Nov 2026 |
| US 8,557,833 | In force Jul 2027 | Jul 2027 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 21, 2007 Reel 19465, frame 790 | Binch, Hayley; Mortimore, Michael; Fraysse, Damien; Rutherford, Alistair | Vertex Pharmaceuticals Incorporated | Assignment of Assignor's Interest |
| Jul 10, 2014 Reel 33292, frame 311 | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Macquarie US Trading LLC | Security Interest |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated | Release of Security Interest |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
| Oct 14, 2016 Reel 40357, frame 1 | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 7,767,672, ends no earlier than this term, so it caps nothing.